Karyopharm Initiates Phase 2 Study of Selinexor in Patients With Advanced Gynecologic Malignancies
April 24, 2014 at 07:02 AM EDT
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel ...